Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ATHX:US

1.3500 USD 0.0100 0.74%

As of 20:10:00 ET on 05/27/2015.

Snapshot for Athersys Inc (ATHX)

Open: 1.3400 Day's Range: 1.3400 - 1.3800 Volume: 229,718
Previous Close: 1.3600 52wk Range: 0.9000 - 3.4300 1-Yr Rtn: -17.18%

Stock Chart for ATHX

No chart data available.
  • ATHX:US 1.3500
  • 1D
  • 1M
  • 1Y
1.3600
Interactive ATHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATHX

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3600
Est. EPS (USD) (12/2015) -0.3530
Est. PEG Ratio -
Market Cap (M USD) 111.89
Shares Outstanding (M) 82.88
30 Day Average Volume 2,602,258
Price/Book (mrq) 5.8151
Price/Sale (ttm) 64.0239
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATHX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ATHX

Athersys Incorporated is a clinical-stage biotechnology company. The Company develops allogeneic stem cell products that focus on treating inflammatory and immune disorders, neurological conditions, cardiovascular disease, and other conditions.

Gil Van BokkelenChairman/CEO/Co-FounderWilliam O Lehmann Jr "BJ"President/COO/Secretary
John J HarringtonExec VP/Chief Scientific OfcrRobert J DeansExec VP:Regenerative Medicine
More Company Profile & Key Executives for ATHX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil